On This Page

Filter

These are the filters currently being used to limit the search results. Click on the
icon to remove the filter.

tabling member printed

Baroness Thomas of Winchester

min date

2019-05-07

answering body

Department of Health and Social Care

min answer › question first answered

2019-05-15T12:39:20.147Z

answer › is ministerial correction

false

hansard heading

National Institute for Health and Care Excellence

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are
shown at the top of the list. Click on to remove a sort and or to reverse the current sort order. Click on the icon to remove all the sorting. Note that sorting can significantly slow down the
loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined
views, but starred properties are always present no matter what the view. You can
star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

<p>Departmental officials are in regular contact with colleagues in the National Institute
for Health and Care Excellence (NICE) and NHS England about a range of issues, including
progress in discussions about a potential managed access agreement for Spinraza (nusinersen).
Ministers have also held meetings with Biogen, NICE and NHS England on a number of
occasions, at which the availability of Spinraza was discussed.</p><p>NHS England
and NICE have made stakeholders and the public aware of the outcome of its appraisal
committee meeting and NICE is now able to recommend the use of Spinraza for National
Health Service patients in England, subject to a managed access agreement agreed between
NHS England and Biogen. The final appraisal document will be published in due course.</p><p>
</p>